Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on December 7, 2007. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

65 -- Medicare Part B Drugs - Competitive Acquisition Program

Closed
RFP-CMS-2008-CAP2Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 424210
New
International
Pralidoxime
Solicitation # W6369-26-A033/B
The Department of National Defence, through the Strategic Medical Countermeasures Program, is soliciting offers for the procurement of Pralidoxime Chloride or Pralidoxime Methyl Sulfate to treat Canadian Armed Forces members exposed to chemical warfare agents. The contract includes an initial requirement for 450 treatment courses to be delivered by March 31, 2027, with optional requirements for an additional 600 doses to be delivered between April 1, 2027, and March 31, 2031. A treatment course is defined as 1 gram per day for seven days. The award will be granted to the compliant offer with the lowest evaluated price, based on Delivered at Place terms for the Central Medical Equipment Depot in Petawawa, Ontario. Technical requirements mandate that the product be manufactured according to current Good Manufacturing Practices and hold a Health Canada issued Notice of Compliance or appropriate authorization. The medication must have a minimum shelf-life of 36 months from the date of manufacture and be delivered in a temperature-controlled environment, specifically maintained between 2 to 8 degrees Celsius, with continuous electronic monitoring and a Certificate of Conformity provided upon delivery. All packaging and drug inserts must be available in English or French. There are no security requirements associated with this procurement, and the solicitation is open to Canadian suppliers and those of applicable trading partners.
Department of National Defence

POSTED

1 day ago

DEADLINE

in 20 days

AI Contract Overview

Show more

The Centers for Medicare & Medicaid Services is seeking vendors to supply specific Medicare Part B drugs and biologicals through the Competitive Acquisition Program. The contract period is scheduled to run from January 1, 2009, through December 31, 2011. The solicitation process is expected to begin on January 14, 2008, with the bidding window closing on February 15, 2008. To be eligible for an award, vendors must be enrolled as Medicare suppliers by completing CMS Form 855B. Additionally, the vendor and any associated subcontractors or affiliates must hold the necessary state and federal licenses to distribute drugs across all 50 U.S. states, the District of Columbia, and various U.S. territories, including Puerto Rico, the Virgin Islands, American Samoa, Guam, and the Northern Mariana Islands.

General Info

Agency

N/A

NAICS

424210 - Drugs and Druggists' Sundries Merchant Wholesalers

Place of Performance

Department of Health and Human Services, Centers for Medicare & Medicaid Services, 7500 Security Blvd, MS C4-01-26, Baltimore,

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseClosed
Posted

Presolicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts

Full Description

Show more
The Centers for Medicare & Medicaid Services (CMS) anticipates releasing a solicitation for contracts to be awarded to vendors in order to supply certain Medicare Part B drugs and biologicals in a designated competitive acquisition area under the Competitive Acquisition Program (CAP) for Part B Drugs. Information on the CAP can be found in section 1847B of the Social Security Act, as added by section 303(d) of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (MMA) and amended by Section 108 of the Medicare Improvements and Extension Act of 2006 (MIEA-TRHCA). The CAP solicitation is tentatively scheduled to be released on January 14, 2008 and the bidding period will end on February 15, 2008. The contract period will begin on January 1, 2009 and will end on December 31, 2011. Additional information about the CAP may be found at the following CMS website: http://www.cms.hhs.gov/CompetitiveAcquisforBios/01_overview.asp Bidding forms and background information on the previous bidding period may be found at: http://www.cms.hhs.gov/CompetitiveAcquisforBios/03a_vendorbackground.asp A list of drugs currently supplied under the CAP may be found at: http://www.cms.hhs.gov/CompetitiveAcquisforBios/Downloads/CAPDrugList.pdf This announcement also serves to notify vendors in advance of some of the solicitation requirements. In order to be considered for award of a contract under the CAP, a vendor must complete a CMS Form 855B and be enrolled as a Medicare supplier. The CMS Form 855B is available at: http://www.cms.hhs.gov/CMSforms/downloads/cms855b.pdf In addition, a vendor, including any of its subcontractors, subsidiaries, or business affiliates, must also be licensed in accordance with state and Federal requirements and in a manner that will allow the applicant to supply CAP drugs in all 50 States, the District of Columbia, Puerto Rico, The United States Virgin Islands, American Samoa, Guam and the Northern Mariana Islands. You are reminded that the information provided in this announcement is for advance planning only and is not a request for proposal. The formal solicitation is anticipated to be released in January. CAP PRIMARY POINT OF CONTACT While we do not expect to be able to provide any additional information about the CAP prior to the release of the solicitation in January, any questions may be directed to Bonny C. Dahm, Health Insurance Specialist, at (410) 786- 4006, Fax (410) 786-4490 or via E-mail at bonny.dahm@cms.hhs.gov.

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS